SSSanne P. Smeekens

Sanne P. Smeekens

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sanne P. Smeekens has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimizing Genetic Analyses for Movement Disorders: A Unified Panel Approach and Targeted Reanalysis of 4,046 Clinical Exomes

    by Teodora Barbarii, Sanne P. Smeekens, Maartje Pennings, Galuh Astuti, Lisenka E.L.M. Vissers, Helger G. Yntema, Christian Gilissen, Bart van de Warrenburg, Erik‐Jan Kamsteeg

    Background: Molecular testing for genetic movement disorders (MDs) increasingly relies on exome‐ or genome‐based virtual gene panels. In the absence of consensus guidelines, MD panel design remains heterogeneous across laboratories, with international variation in panel configuration and gene content. Objective: The aim of this work was to develop a reproducible framework for a unified MD panel design, generate a comprehensive, curated gene‐phenotype dataset, and evaluate clinical utility via targeted exome reanalysis. Methods: Candidate genes were extracted from multiple resources and assessed using predefined criteria for panel inclusion and gene‐disease validity. Genes were tiered as Green, Amber, or Red based on evidence strength. Phenotypic spectrum and age at onset were assessed for Green genes based on published literature. Newly added Green and Amber genes were investigated in 4,046 exomes from previously undiagnosed MD cases. Results: Among 2,090 extracted genes, 640 were selected. The final panel included 537 Green, 36 Amber, and 67 Red genes, expanding the prior panel by 283 genes and removing 42. Across Green genes, only 17% were linked to a single MD feature, whereas the remainder associated up to eight. Age‐at‐onset data indicated both pediatric and adult presentations in 43% of genes. Targeted exome reanalysis using a 220‐gene list identified 37 clinically relevant variants across 28 genes, resolving 16 cases and increasing diagnostic yield by 0.4%. Conclusions: This study offers a systematic framework for designing a unified MD panel by integrating evidence from multiple sources and accounting for phenotypic and age heterogeneity. Targeted reanalysis yielded actionable diagnoses, confirming its benefit in routine clinical practice. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

  • Open Access

    Detection of DNA Contamination in Prenatal Samples from Whole Exome Sequencing Data

    by Sanne P Smeekens, Raoul Timmermans, Dineke Westra, Christian Gilissen, Brigitte H W Faas

    Background: Maternal cell contamination (MCC) in prenatal samples poses a risk for misdiagnosis, and therefore, testing for contamination is necessary during genetic analysis of prenatal specimens. MCC testing is currently performed as a method separate from the diagnostic method. With the increasing application of whole exome sequencing (WES) in prenatal diagnosis, we sought to develop a method to estimate the level of contamination from WES data, aiming to eliminate the need for a separate MCC test. Methods: To investigate the impact of MCC on the distribution of the variant allele fraction in WES data, contamination was both simulated in silico and artificially induced. Subsequently, a bioinformatic WES contamination method was developed and validated by comparing its performance to that of the gold standard (short tandem repeat [STR]) MCC test, validated for detecting ≥5% contamination. Finally, post-implementation performance was monitored for a 15-month period. Results: During validation, 270 prenatal samples underwent analysis with both WES and the gold standard test. In 259 samples, the results were concordant (248 not contaminated, 11 contaminated with both tests). In 11 samples, contamination was only detected in WES data (2 of which contained ≥5% contamination with WES, which is above the detection limit of the gold standard test). The data of the post-implementation evaluation on 361 samples, of which 68 were contaminated, were in line with the validation data. Conclusions: Contamination can reliably be detected in WES data, rendering a separate contamination test unnecessary for the majority of samples.


  • Open Access

    Maternal cell contamination in postnatal umbilical cord blood samples implies a low risk for genetic misdiagnoses

    by Sanne P. Smeekens, Maike. Leferink, Helger G. Yntema, Erik‐Jan Kamsteeg

    Objective: Maternal cell contamination (MCC) poses a risk for misdiagnosis in prenatal genetic testing, and is examined in accredited diagnostic laboratories However, the awareness of possible MCC in perinatal/postnatal genetic testing, mainly of umbilical cord blood (CB), is lower.Method: We investigated the rate of MCC in DNA from both umbilical CB samples and umbilical cord samples that were sent to our diagnostic laboratory for diagnostic testing between 1995 and 2021 (n = 236).Results: MCC was detected in 4% of umbilical CB samples, and in one umbilical cord sample. Particularly tests enriching for a specific variant are very sensitive for low amounts of MCC, as we emphasize here with a false positive diagnosis of myotonic dystrophy type 1 in a newborn.Conclusions: Overall, with appropriate collection and use, umbilical CB and umbilical cord samples are suitable for genetic testing based on the low rates of MCC and misdiagnosis. These findings do however underline the importance of routine MCC testing in umbilical CB samples and umbilical cord samples for both requesting clinicians and diagnostic genetic laboratories.


  • Seasonal and Nonseasonal Longitudinal Variation of Immune Function

    by Rob ter Horst, Martin Jaeger, Lisa van de Wijer, Wouter A van der Heijden, Anna M W Janssen, Sanne P Smeekens, Michelle A E Brouwer, Bram van Cranenbroek, Raul Aguirre-Gamboa, Romana T Netea-Maier, et al.

    Different components of the immune response show large variability between individuals, but they also vary within the same individual because of host and environmental factors. In this study, we report an extensive analysis of the immune characteristics of 56 individuals over four timepoints in 1 single year as part of the Human Functional Genomics Project. We characterized 102 cell subsets using flow cytometry; quantified production of eight cytokines and two chemokines in response to 20 metabolic, bacterial, fungal, and viral stimuli; and measured circulating markers of inflammation. Taking advantage of the longitudinal sampling, both seasonal and nonseasonal sources of variability were studied. The circulating markers of inflammation IL-18, IL-18 binding protein, and resistin displayed clear seasonal variability, whereas the strongest effect was observed for α-1 antitrypsin. Cytokine production capacity also showed strong seasonal changes, especially after stimulation with the influenza virus, Borrelia burgdorferi, and Escherichia coli. Furthermore, we observed moderate seasonality effects on immune cell counts, especially in several CD4+/CD8+ T cell subpopulations. Age of the volunteers was an important factor influencing IFN-γ and IL-22 production, which matched the strong impact of age on several T cell subsets. Finally, on average, genetics accounted for almost 50% of the interindividual variance not already explained by age, sex, and body mass index, although this varies strongly for different parameters. In conclusion, seasonality is an important environmental factor that influences immune responses, in addition to specific genetic and nongenetic host factors, and this may well explain the seasonal variation in the incidence and severity of immune-mediated diseases.


  • Human recombinant interleukin-38 suppresses inflammation in mouse models of local and systemic disease

    by Dennis M. de Graaf, Ralph J.A. Maas, Sanne P. Smeekens, Elan Eisenmesser, Jasmina S. Redzic, Monique M. Helsen, Nicholas E. Powers, Suzhao Li, Vassili Kalabokis, Mark S. Gresnigt, et al.


  • Open Access

    Erratum: Corrigendum: Inter-individual variability and genetic influences on cytokine responses to bacteria and fungi

    by Yang Li, Marije Oosting, Patrick Deelen, Isis Ricaño-Ponce, Sanne Smeekens, Martin Jaeger, Vasiliki Matzaraki, Morris A Swertz, Ramnik J Xavier, Lude Franke, et al.